| Issue |
Section |
Title |
File |
| Vol 13, No 1 (2015) |
Articles |
Influence of V2 vasopressin receptor agonist, 1-dezamino-8-D-arginine-vasopressin, DAVP, on a sensitivity disorders in stroke patients |
(Rus)
|
| Vol 12, No 1 (2014) |
Articles |
Disturbances of verbal memory and learning in patients with cerebrovascular diseases and the possibilities of their correction using arginine-vasopressin |
(Rus)
|
| Vol 11, No 4 (2013) |
Articles |
Agonist of V 2 vasopressin receptor, 1-dezamino-8-D-arginine-vasopressin, reduces parkinson's disease symptoms |
(Rus)
|
| Vol 12, No 3 (2014) |
Articles |
Neuropeptide vasopressin and memory process |
(Rus)
|
| Vol 14, No 3 (2016) |
Articles |
Efficacy of selective agonist V2 vasopressin receptor, 1-dezamino-8-D-arginine-vasopressin, in the treatment of pain in patients with degenerative-dystrophic diseases of the spine |
|
| Vol 14, No 4 (2016) |
Articles |
Activation of V2 vasopressin receptors induces recovery of motor function in patients with stroke, Parkinson’s disease and parkinsonism of different nature |
|
| Vol 16, No 3 (2018) |
Articles |
Vasopressin in mechanisms of stress reactions and modulation of emotion |
(Rus)
|
| Vol 19, No 3 (2021) |
Reviews |
Antioxidant and prooxidant systems in patients with ischemic insult |
(Rus)
|
| Vol 21, No 3 (2023) |
Reviews |
Role of oxidative stress in the pathogenesis of autism spectrum disorders |
|
